• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

The recommendations listed in this guideline are, whenever possible, evidence based. An
initial extensive evidence review, which included literature derived from research involving …

Importance Myocarditis is a leading cause of sudden death in competitive athletes.
Myocardial inflammation is known to occur with SARS-CoV-2. Different screening …

Myocarditis is an inflammatory disease of the heart that may occur because of infections,
immune system activation, or exposure to drugs. The diagnosis of myocarditis has changed …

or therapeutic medical strategies. However, the ESC Guidelines do not override in any way
whatsoever the individual responsibility of health professionals to make appropriate and …

Importance Acute myocarditis, defined as a sudden inflammatory injury to the myocardium,
affects approximately 4 to 14 people per 100 000 each year globally and is associated with …

Summary Each year, the American Heart Association (AHA), in conjunction with the National
Institutes of Health and other government agencies, brings together in a single document the …

The recommendations listed in this clinical practice guideline are, whenever possible,
evidence-based. An initial extensive evidence review, which included literature derived from …

Background: There is controversy about the outcome of patients with acute myocarditis (AM),
and data are lacking on how patients admitted with suspected AM are managed. We report …

Background: Accurate knowledge of causes of sudden cardiac death (SCD) in athletes and
its precipitating factors is necessary to establish preventative strategies. Objectives: This …